Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2008

Mar 4, 2008

34595_dirs_2008-03-04_9176ce0f-0f7a-488b-8781-b0a4b4065145.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2008-02-28

Reporting Person: KISSINGER PETER (10% Owner)
Reporting Person: KISSINGER CANDICE B (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-28 Common Stock S 300 $6.00 Disposed 1026557 Direct
2008-02-29 Common Stock S 100 $6.00 Disposed 1026457 Direct
2008-02-29 Common Stock S 100 $6.14 Disposed 1026357 Direct
2008-02-29 Common Stock S 200 $6.13 Disposed 1026157 Direct
2008-02-29 Common Stock S 100 $6.12 Disposed 1026057 Direct
2008-02-29 Common Stock S 100 $6.09 Disposed 1025957 Direct
2008-03-03 Common Stock S 500 $6.00 Disposed 1025457 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 848220 Direct

Footnotes

F1: Shares sold were held by Peter T. Kissinger individually; direct holdings of Peter T. Kissinger after this transaction include 595,910 shares held jointly with Candice B. Kissinger. Shares that are reported as individually held by Candice B. Kissinger or held jointly by Candice B. Kissinger and her children are deemed to be indirectly held by Peter T. Kissinger.

F2: Shares held directly by Candice B. Kissinger; includes 595,910 shares held jointly by Peter T. Kissinger and Candice B. Kissinger and 1,354 shares held jointly by Candice B. Kissinger and her children. Shares that are reported as individually held by Peter T. Kissinger are deemed to be indirectly held by Candice B. Kissinger.